Related Experiment Video
Updated: Jun 25, 2026

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System
Published on: May 5, 2018
Reversible foetal cerebral ventriculomegaly and cardiomyopathy under chemotherapy for maternal AML
Anne K Baumgärtner1, R Oberhoffer, Volker R Jacobs
1Abteilung Perinatalmedizin, Frauenklinik rechts der Isar der Technischen Universitat München, Ismaninger Strasse 22, Munich, Germany. annebaumgaertner@web.de
Background:
Leukaemia in pregnancy is a rare complication demanding a multidisciplinary approach and careful management to handle potential complications and cope with ethical dilemmas.
Patient And Methods:
We report on a patient with acute myeloid leukaemia (AML) relapse in 22 weeks of gestation who received chemotherapy with cytarabine and mitoxantrone, as well as fludarabine, cytarabine, idarubicin, and gemtuzumabozogamicin. We describe findings on regular ultrasound examinations and successful management of complications.
Results:
The foetus developed signs of anthracycline-induced cardiomyopathy, transient cerebral ventriculomegaly, anaemia, and intrauterine growth restriction. The child was delivered by Caesarean section at 33 + 1 weeks of gestation. The newborn showed no congenital malformations.
Conclusion:
This case report confirms that chemotherapy for treatment of AML can be applied in the second trimester of pregnancy under close and careful maternal and foetal monitoring.
More Related Videos
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
14:58Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cytomegalovirus Disease
Cardiomyopathy II: Dilated Cardiomyopathy
Teratogenicity